Article Text

Download PDFPDF
KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma
  1. Qiu-Ting Li1,
  2. Yi-Ming Feng2,
  3. Zun-Hui Ke3,
  4. Meng-Jun Qiu1,
  5. Xiao-Xiao He1,
  6. Meng-Meng Wang1,
  7. Ya-Nan Li1,
  8. Jing Xu4,
  9. Liang-Liang Shi5,
  10. Zhi-Fan Xiong1
  1. 1Division of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  2. 2Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  3. 3Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
  4. 4Department of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
  5. 5Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  1. Correspondence to Professor Zhi-Fan Xiong, Division of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, China; xiongzhifan{at}126.com

Abstract

Hepatocellular Carcinoma (HCC) is one of the most common malignancies in the world, and is well-known for its bad prognosis. Potassium calcium-activated channel subfamily N member 4 (KCNN4) is a type of intermediate conductance calcium-activated potassium channel, and increasing evidence suggests that KCNN4 contributes to the regulation of invasion and metastasis in a number of cancers. However, its clinical significance and biological function remain unclear in the HCC disease process. In this study, the expression levels of KCNN4 in 86 HCC samples were compared with corresponding paracancerous tissues. sh-RNA was used to reduce the expression of KCNN4 in Hep3B HCC cells in vitro; this was confirmed by Real time-PCR and western blotting. Wound healing, transwell assays and high content analysis were performed to investigate the tumor-promoting characteristics of KCNN4 in Hep3B HCC cells. As results, KCNN4 expression was significantly associated with preoperative serum alpha-fetoprotein level (p=0.038) and TNM stage (p=0.039). Additionally, patients with high KCNN4 amplification in HCC tissue exhibited shorter disease-free survival, whereas there was no statistical significance between KCNN4 amplification and overall survival. Wound healing and transwell assays showed that knockdown of KCNN4 expression could reduce migration and invasion abilities of HCC cells. High content analysis result showed that down-regulated KCNN4 could inhibit the ability of HCC cell proliferation. The mitogen-activated protein kinase (MAPK) pathway is active in cell proliferation, differentiation, migration, senescence, and apoptosis. Matrix metallopeptidase 9 and extracellular signal regulated kinase 1/2 (ERK1/2) were important biomarkers of MAPK/ERK pathway, knockdown of KCNN4 reduced the expression of MMP9 and ERK1/2. These findings showed that KCNN4 promotes HCC invasion and metastasis through the MAPK/ERK pathway.

  • carcinoma, hepatocellular
  • biological markers
  • medical research
View Full Text

Statistics from Altmetric.com

Footnotes

  • Q-TL and Y-MF contributed equally.

  • Contributors Conceived and designed the experiments: QT Li, ZF Xiong and LL Shi. Performed the experiments: ZH Ke, QT Li, MJ Qiu and XX He. Analyzed the data: YM Feng, MM Wang, YN Li and JX. Contributed reagents/materials/analysis tools: ZF Xiong and LL Shi. Wrote the paper: QT Li, YM Feng.

  • Funding This study was supported by the National Natural Science Foundation of China (No.81702885) and the Fundamental Research Funds for the Central Universities: the Independent Innovation Fund of Huazhong University of Science and Technology (No:2018KFYYXJJ106).

  • Competing interests None declared.

  • Ethics approval This study was approved by the Ethics Committee of the Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.